Morning Overview on MSN

CAR-T therapy sends 3 autoimmune diseases into remission in 1 patient

A woman in her thirties who was dependent on blood transfusions and unresponsive to every standard treatment for her three ...

Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.